Yoshikazu Nakaoka

17PUBLICATIONS
51CO-AUTHORS
Respiratory diseasesPharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)Cardiology (incl. cardiovascular diseases)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 01, 2026
Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database.

Sari Horiuchi, Yukumitsu Kudo, Kotaro Kawano

|Apr 16, 2025
Balloon Pulmonary Angioplasty in Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi

|Mar 19, 2025
Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis.

Hajime Yoshifuji, Tomonori Ishii, Hiroki Ohashi

|Jan 27, 2025
Relationship Between RNF213 p.R4810K and Echocardiographic Findings in Patients with Cerebrovascular Diseases: A Multicenter Prospective Cohort Study.

Kotaro Noda, Yorito Hattori, Tatsuya Nishii

|Sep 09, 2024
Gut Dysbiosis in Patients With Fontan Circulation.

Hideo Ohuchi, Ryotaro Asano, Aki Mori

|Jul 26, 2024
Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi

Pageof 3

Frequent Collaborators

6 joint publications

Ryotaro Asano

6 joint publications

Tomohiko Ishibashi

4 joint publications

Masayoshi Harigai

4 joint publications

Takeshi Ogo